|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||2.34 / 9.58|
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that it has completed the acquisition of Metabasis Therapeutics, Inc.
Several small-cap stocks were poised to move on above-average volume during Tuesday's session.
Several small-cap stocks were moving on above-average volume during Thursday's session.
The stock rises on unusual volume as news of an acquisition emerges.
Cortex Pharma climbs on greenlight from the FDA for an Alzheimer's trial.
Shares slump on disappointing results for type 2 diabetes candidate CS-917.
It boasts best-in-class drugs, but its bump from Tamiflu is temporary and its valuation implies risk.